| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |